Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MarineMax | HZO | Nov 27, 2024 | 32.52 | +1.12 |
Marinus Pharmaceuticals | MRNS | Nov 27, 2024 | 0.32 | +0.93 |
Maris-Tech | MTEK | Nov 27, 2024 | 2.10 | -5.41 |
Markel | MKL | Nov 27, 2024 | 1 785.11 | +0.53 |
Marker Therapeutics | MRKR | Nov 27, 2024 | 3.19 | -2.15 |
Market Vectors Bdc Income ETF | BIZD | Nov 27, 2024 | 16.80 | +0.48 |
Market Vectors Investment Grade | FLTR | Nov 27, 2024 | 25.52 | +0.04 |
Market Vectors Israel ETF | ISRA | Nov 27, 2024 | 42.62 | -1.05 |
Market Vectors Preferred Securi | PFXF | Nov 27, 2024 | 18.01 | +0.11 |
MarketAxess | MKTX | Nov 27, 2024 | 261.71 | +0.26 |
MarketWise A | MKTW | Nov 27, 2024 | 0.50 | -1.38 |
Markforged | MKFG | Nov 27, 2024 | 3.97 | -2.93 |
Marpai A | MRAI | Nov 27, 2024 | 1.94 | 0.00 |
Marqeta A | MQ | Nov 27, 2024 | 3.88 | +1.31 |
Marriott International A | MAR | Nov 27, 2024 | 285.60 | -0.90 |
Marriott Vacations Worldwide | VAC | Nov 27, 2024 | 96.84 | +0.36 |
Mars Acquisition | MARX | Nov 27, 2024 | 11.11 | -0.18 |
Mars Acquisition Units | MARXU | Nov 27, 2024 | 11.23 | 0.00 |
Marsh & McLennan Companies | MMC | Nov 27, 2024 | 233.24 | +0.20 |
Marten Tranport | MRTN | Nov 27, 2024 | 17.28 | -0.17 |
Marti Technologies | MRT | Nov 27, 2024 | 2.53 | +4.12 |
Martin Marietta Materials | MLM | Nov 27, 2024 | 595.60 | -0.23 |
Martin Midstream Partners | MMLP | Nov 27, 2024 | 3.99 | 0.00 |
Marvell Technology | MRVL | Nov 27, 2024 | 90.10 | -3.26 |
Masco | MAS | Nov 27, 2024 | 80.42 | -0.36 |
Masimo | MASI | Nov 27, 2024 | 170.89 | -0.80 |
Massimo Group | MAMO | Nov 27, 2024 | 3.17 | -1.86 |
MasTec | MTZ | Nov 27, 2024 | 144.55 | -2.29 |
Mastech Digital | MHH | Nov 27, 2024 | 14.91 | -5.75 |
Masterbrand | MBC | Nov 27, 2024 | 17.18 | -0.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.